Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.
His medical interests include:
Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)
Acute Leukemia
Chronic Leukemia Treatments
Hodgkin Lymphoma
Non-Hodgkin Lymphoma Treatments
Multiple Myeloma Treatments, MDS
Aplastic Anemia
ITP
TTP Treatments
Hypercoagulability
Hereditary Thrombophilia Treatments
Therapeutic Apheresis
Photopheresis
Geriatric Hematology Diseases.
Mostrar másProf. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.
His medical interests include:
Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)
Acute Leukemia
Chronic Leukemia Treatments
Hodgkin Lymphoma
Non-Hodgkin Lymphoma Treatments
Multiple Myeloma Treatments, MDS
Aplastic Anemia
ITP
TTP Treatments
Hypercoagulability
Hereditary Thrombophilia Treatments
Therapeutic Apheresis
Photopheresis
Geriatric Hematology Diseases.
Estetik Cerrahi: Deneyimli cerrahlarımızla, güncel teknikleri kullanarak estetik cerrahi hizmetleri sunuyoruz. Her bireyin ihtiyacına özel çözümler üreterek, doğal ve estetik sonuçlar elde etmeyi amaçlıyoruz.
Saç, Sakal ve Kaş Ekimi: Saç dökülmesi, seyrek sakal ya da kaş problemleriyle mücadele edenlere özel çözümler sunuyoruz. Uzman ekibimiz, kişinin yüz hatlarına uygun doğal sonuçlar elde etmeyi hedefler.
Dolgu Uygulamaları: Yüz gençleştirme ve kontürleme amacıyla kullanılan dolgu uygulamalarını, uzman estetik cerrahlarımız ile güvenli bir şekilde gerçekleştiriyoruz. Doğallığı ön planda tutan yaklaşımımızla, müşterilerimize istedikleri görünüme kavuşmalarında yardımcı oluyoruz.
Mostrar másEstetik Cerrahi: Deneyimli cerrahlarımızla, güncel teknikleri kullanarak estetik cerrahi hizmetleri sunuyoruz. Her bireyin ihtiyacına özel çözümler üreterek, doğal ve estetik sonuçlar elde etmeyi amaçlıyoruz.
Saç, Sakal ve Kaş Ekimi: Saç dökülmesi, seyrek sakal ya da kaş problemleriyle mücadele edenlere özel çözümler sunuyoruz. Uzman ekibimiz, kişinin yüz hatlarına uygun doğal sonuçlar elde etmeyi hedefler.
Dolgu Uygulamaları: Yüz gençleştirme ve kontürleme amacıyla kullanılan dolgu uygulamalarını, uzman estetik cerrahlarımız ile güvenli bir şekilde gerçekleştiriyoruz. Doğallığı ön planda tutan yaklaşımımızla, müşterilerimize istedikleri görünüme kavuşmalarında yardımcı oluyoruz.
El Prof. Jaroslav Michalek es un especialista experimentado en oncología, pediatría, alergología e inmunología clínica con una patente europea para el aislamiento de células madre. Tiene 16 años de experiencia en medicina regenerativa, es presidente del Consorcio Internacional de Terapia Celular e Inmunoterapia, es autor de más de 200 publicaciones, fue profesor en la Universidad Masaryk de 2007 a 2015, obtuvo una beca posdoctoral en la Universidad de Texas Southwestern Facultad de Medicina, y es miembro de múltiples asociaciones profesionales.
Mostrar másEl Prof. Jaroslav Michalek es un especialista experimentado en oncología, pediatría, alergología e inmunología clínica con una patente europea para el aislamiento de células madre. Tiene 16 años de experiencia en medicina regenerativa, es presidente del Consorcio Internacional de Terapia Celular e Inmunoterapia, es autor de más de 200 publicaciones, fue profesor en la Universidad Masaryk de 2007 a 2015, obtuvo una beca posdoctoral en la Universidad de Texas Southwestern Facultad de Medicina, y es miembro de múltiples asociaciones profesionales.
Director Médico de la Clínica Universidad de Navarra
Prof. de hematología y hemoterapia
Mostrar másDirector Médico de la Clínica Universidad de Navarra
Prof. de hematología y hemoterapia
Profesor, especialista en oncohematología
Mostrar másProfesor, especialista en oncohematología